Eli Lilly dominated the pharma landscape in 2025 powered by the exponential growth of the GLP-1 receptor agonist (RA) market to become the largest company in the industry by market cap, with the road ahead expected to be even more lucrative
For Broussenko, the gap between demand and actual access was enormous but he also sees generic semaglutide as a turning point in a public health crisis that has persisted in Canada for decades
When blood sugar is too high, the kidneys work harder to remove excess glucose through urine, a process called osmotic diuresis
Key factors associated with adherence to physical exercise in patients with chronic diseases and older adults: an umbrella review
For example, a patient who was using Ozempic for diabetes might reach their goal but still need weight management support, and their doctor might transition them to Wegovy
Disturbed lipid and amino acid metabolisms in COVID-19 patients